NCT01503944
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +15 more
- Locations
-
- Research Site Sun City, Arizona, United States
- Research Site Philadelphia, Pennsylvania, United States
Clinical trial condition
Basal Ganglia Diseases
Explore clinical trials studying Basal Ganglia Diseases. Study availability and eligibility vary by location and protocol.
4,056 public trials
750 recruiting studies
Basal Ganglia Diseases trial results
NCT01313845
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Seoul National University Bundang Hospital Seongnam, South Korea
- Hanyang University Medical Center Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
- Seoul National University Boramae Hospital Seoul, South Korea
Completed
Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease
NCT01355835
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Center of Neurology and Hertie Institute for Clinical Brain Research, and Department for Neurodegenerative Diseases, University of Tübingen Tübingen, Baden-Wurttemberg, Germany
NCT01290861
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- University of California, San Diego La Jolla, California, United States
- University of California, Los Angeles Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of South Florida Tampa, Florida, United States
NCT01142739
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- CHU de Bordeaux Hôpital Haut Lévêque Pessac, France
Completed
Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women
NCT01652313
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- CN001 Beijing, China
Completed
ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
NCT01336088
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Addex Investigator Site Birmingham, Alabama, United States
- Addex Investigator Site Phoenix, Arizona, United States
- Addex Investigator Site La Jolla, California, United States
- Addex Investigator Site Los Angeles, California, United States
NCT01634568
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Hammersmith Medicines Research London, United Kingdom
NCT00841464
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Philadelphia VA Medical Center Philadelphia, Pennsylvania, United States
NCT00215904
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Ezrath Nashim - Herzog Memorial Hospital Jerusalem, Israel